The World Health Organization mentioned any WHO stamp of approval on a COVID-19 vaccine candidate would require a rigorous safety data review, after Russia introduced Tuesday it had authorized a vaccine.
President Vladimir Putin mentioned Russia had develop into the primary nation to approve a vaccine providing “sustainable immunity” in opposition to the brand new coronavirus.
“We are in close contact with the Russian health authorities and discussions are ongoing with respect to possible WHO pre-qualification of the vaccine,” mentioned the United Nations well being company’s spokesman Tarik Jasarevic.
“Pre-qualification of any vaccine includes the rigorous review and assessment of all the required safety and efficacy data,” he instructed reporters in Geneva at a web based press briefing.
Russia’s Sputnik V vaccine has been developed by the Gamaleya analysis institute in coordination with the nation’s defence ministry.
A complete of 168 candidate vaccines are being labored on world wide, in accordance to a WHO overview revealed Tuesday.
Of these, 28 have progressed to the assorted phases of being examined on people, of which six are the furthest forward, having reached Phase three of scientific trials.
The Gamaleya candidate, which is among the many 28 in scientific analysis, is listed as solely being in Phase 1.
Kirill Dmitriev, the top of the Russian Direct Investment Fund which funds the vaccine venture, mentioned Phase three trials would begin on Wednesday, industrial production was anticipated from September and that 20 nations had pre-ordered greater than a billion doses.
‘Stamp of high quality’
“Every country has national regulatory agencies that approve the use of vaccines or medicines on its territory,” Jasarevic defined.
“WHO has in place a means of pre-qualification for vaccines but additionally for medicines. Manufacturers ask to have the WHO pre-qualification as a result of it’s a type of stamp of high quality.
“To get this, there is a review and assessment of all required safety and efficacy data that are gathered through the clinical trials. WHO will do this for any candidate vaccine.”
The pandemic has seen an unprecedented mobilisation of funding and analysis to rush by a vaccine that may defend billions of individuals worldwide.
“We are encouraged by the speed by which several candidate vaccines have been developing and as we have been always saying, we hope some of these vaccines will prove to be safe and efficient,” mentioned Jasarevic.
“Accelerating progress does not mean compromising on safety,” he mentioned.
© 2020 AFP
WHO wants to review Russian vaccine safety data (2020, August 11)
retrieved 11 August 2020
This doc is topic to copyright. Apart from any truthful dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.